FDA official warns on nonprescription sleep pills
Washington The FDA commissioner told a Senate hearing that the key antihistamine in many nonprescription sleep aids may worsen sleep by suppressing REM dreams and causing night mares when the drug is skipped. He cited risks of nervousness digestion issues dry mouth and blurred vision plus concerns over other ingredients like copotamins bromide salts and salicylamide. He noted seizure actions against two promoted sleep products and urged tighter scrutiny to curb mood drug overuse and misleading ads.